What the blood knows: interrogating circulating tumor DNA to predict progression of minimal residual disease in early breast cancer

Ann Transl Med. 2016 Dec;4(24):543. doi: 10.21037/atm.2016.11.77.
No abstract available

Publication types

  • Comment